Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study.

Published on Sep 1, 2019in Diabetes Care16.019
· DOI :10.2337/DC19-0145
Jaelim Cho15
Estimated H-index: 15
(University of Auckland),
Robert Scragg73
Estimated H-index: 73
(University of Auckland)
+ 2 AuthorsMaxim S. Petrov28
Estimated H-index: 28
(University of Auckland)
Sources
Abstract
OBJECTIVE There are no specific treatment guidelines for diabetes of the exocrine pancreas. High-quality studies are warranted to investigate whether the use of antidiabetic medications has survival benefit in individuals with diabetes of the exocrine pancreas. The objective was to determine the risk of mortality associated with the use of antidiabetic medications in individuals with pancreatic cancer–related diabetes (PCRD) and postpancreatitis diabetes mellitus (PPDM). RESEARCH DESIGN AND METHODS Nationwide pharmaceutical dispensing data (2006–2015) linked to hospital discharge data were used to identify 1,862 individuals with PCRD or PPDM. Multivariable Cox regression analysis was conducted, and the risk was expressed as hazard ratios and 95% CIs. A 6-month lag was used to minimize reverse causality. RESULTS In individuals with PCRD, ever users of metformin (adjusted hazard ratio 0.54; 95% CI 0.46–0.63) and ever users of insulin (adjusted hazard ratio 0.46; 95% CI 0.39–0.55) had significantly lower risks of mortality compared with never users of antidiabetic medications. These associations attenuated toward the null with the use of a 6-month lag. In individuals with PPDM, ever users of metformin had a significantly lower risk of mortality (adjusted hazard ratio 0.51; 95% CI 0.36–0.70), whereas ever-users of insulin did not have a significantly changed risk of mortality (adjusted hazard ratio 0.75; 95% CI 0.49–1.14) compared with never users of antidiabetic medications. The former association remained significant with the use of a 6-month lag. CONCLUSIONS Metformin promotes a survival benefit in individuals with PPDM but not PCRD. Reverse causality may play a role in the association between insulin use and mortality in PCRD.
📖 Papers frequently viewed together
147 Citations
1 Author (Maxim S. Petrov)
54 Citations
201419.82Gut
168 Citations
References50
Newest
#1Sayali A. Pendharkar (University of Auckland)H-Index: 15
#2Ruma G. SinghH-Index: 14
Last. Maxim S. PetrovH-Index: 28
view all 5 authors...
AIM: To investigate the pancreatic hormone responses to mixed meal test, in particular changes in insulin secretion, insulin sensitivity, and their interrelationship, in individuals with new-onset prediabetes or diabetes after non-necrotizing acute pancreatitis (NODAP) compared with healthy controls. METHODS: Twenty-nine individuals with NODAP and 29 age-and sex-matched healthy controls were recruited. All participants (after fasting for at least 8 h) were given 12 oz. of BOOST drink and blood s...
15 CitationsSource
#1Ruma G. Singh (University of Auckland)H-Index: 14
#2Aya Cervantes (University of Auckland)H-Index: 9
Last. Maxim S. Petrov (University of Auckland)H-Index: 28
view all 8 authors...
Individuals with diabetes after acute pancreatitis have significantly higher intrapancreatic fat percentage and visceral fat volume compared with individuals without diabetes after acute pancreatit...
24 CitationsSource
#1Jaelim Cho (University of Auckland)H-Index: 15
#2Robert Scragg (University of Auckland)H-Index: 73
Last. Maxim S. Petrov (University of Auckland)H-Index: 28
view all 3 authors...
OBJECTIVES: To investigate the risk of mortality and hospitalization in individuals with post-pancreatitis diabetes mellitus (PPDM) compared with those with type 2 diabetes mellitus (T2DM). METHODS: Using nationwide hospital discharge data on pancreatitis and diabetes in New Zealand (n = 231,943), a total of 959 individuals with PPDM were identified. For each individual with PPDM, 10 age- and sex-matched individuals with T2DM were randomly selected. Multivariable Cox regression analysis was cond...
26 CitationsSource
#1Maxim S. Petrov (University of Auckland)H-Index: 30
#2Dhiraj Yadav (University of Pittsburgh)H-Index: 52
Knowledge of pancreatitis in the 20th century was shaped predominantly by animal data and clinical trials. Several large general population-based cohort studies and comprehensive systematic literature reviews in the 21st century have had a major effect on our understanding of pancreatitis and its sequelae. This Review provides precise and up-to-date data on the burden of acute pancreatitis, chronic pancreatitis and post-pancreatitis diabetes mellitus. Exocrine pancreatic insufficiency and altere...
147 CitationsSource
#1Ruma G. Singh (University of Auckland)H-Index: 14
#2Ngoc Nhu Nguyen (University of Auckland)H-Index: 5
Last. Maxim S. Petrov (University of Auckland)H-Index: 28
view all 5 authors...
: Current knowledge of biomarkers of intra-pancreatic fat deposition (IFD) is limited. We aimed to analyse comprehensively body composition and insulin traits as biomarkers of IFD in healthy normoglycaemic individuals as well as in individuals with new-onset prediabetes or diabetes after acute pancreatitis (NODAP). A total of 29 healthy individuals and 34 individuals with NODAP took part in this cross-sectional study. The studied biomarkers belonged to the following domains: body composition (an...
33 CitationsSource
#1Jaelim Cho (University of Auckland)H-Index: 15
#2Monika Walia (University of Auckland)H-Index: 3
Last. Maxim S. Petrov (University of Auckland)H-Index: 28
view all 4 authors...
AbstractObjective: To investigate the frequency and risk factors for mental disorders following pancreatitis.Methods: Patients with acute pancreatitis (AP) and chronic pancreatitis (CP) were identified (n = 18,074) from a nationwide database in New Zealand (1998–2015). They were followed from their first hospital admissions for AP or CP to incident mental disorders. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using multivariable Cox regression analyses.Results: CP (vs AP)...
11 CitationsSource
Purpose of review The relationship between pancreatic ductal adenocarcinoma (PDAC) and diabetes mellitus (DM) is complex. We reviewed the recent medical literature regarding the effect of anti-diabetic medication on PDAC risk and survival, risk of PDAC in DM, and role of DM in early detection of PDAC.
11 CitationsSource
#1Bram Stynen (UdeM: Université de Montréal)H-Index: 4
#2Diala Abd-Rabbo (UdeM: Université de Montréal)H-Index: 3
Last. Stephen W. Michnick (UdeM: Université de Montréal)H-Index: 54
view all 8 authors...
Summary We report here a simple and global strategy to map out gene functions and target pathways of drugs, toxins, or other small molecules based on “homomer dynamics” protein-fragment complementation assays ( hd PCA). hd PCA measures changes in self-association (homomerization) of over 3,500 yeast proteins in yeast grown under different conditions. hd PCA complements genetic interaction measurements while eliminating the confounding effects of gene ablation. We demonstrate that hd PCA accurate...
22 CitationsSource
#1Maxim S. Petrov (University of Auckland)H-Index: 30
19 CitationsSource
#1Ruma G. Singh (University of Auckland)H-Index: 14
#2Sayali A. Pendharkar (University of Auckland)H-Index: 15
Last. Maxim S. Petrov (University of Auckland)H-Index: 28
view all 6 authors...
Abstract Background Emerging evidence indicates that individuals after an episode of acute pancreatitis (AP) are at an increased risk of developing metabolic derangements. While the link between general obesity and insulin resistance (IR) is well established, only a few studies have investigated the association between abdominal obesity and IR. The aim of this study was to investigate the associations between abdominal obesity and several indices of IR in individuals after an episode of AP. Meth...
28 CitationsSource
Cited By31
Newest
#1Xiaoye Duan (Peking Union Medical College)
#2Weihao Wang (Peking Union Medical College)H-Index: 3
Last. Lixin Guo (Peking Union Medical College)H-Index: 2
view all 0 authors...
The relationship between type 2 diabetes mellitus (T2DM) and pancreatic cancer (PC) is complex. Diabetes is a known risk factor for PC, and new-onset diabetes (NOD) could be an early manifestation of PC that may be facilitate the early diagnosis of PC. Metformin offers a clear benefit of inhibiting PC, whereas insulin therapy may increase the risk of PC development. No evidence has shown that novel hypoglycemic drugs help or prevent PC. In this review, the effects of T2DM on PC development are s...
Source
Source
#1Phil A Hart (NIH: National Institutes of Health)
#2Dana K. Andersen (NIH: National Institutes of Health)H-Index: 21
Last. Mark O. Goodarzi (Cedars-Sinai Medical Center)H-Index: 67
view all 4 authors...
PURPOSE OF REVIEW Diabetes secondary to pancreatic diseases (i.e., acute pancreatitis, chronic pancreatitis, and pancreatic cancer) is increasingly studied, but remains challenging to distinguish from type 2 diabetes (T2DM). We review the clinical significance and potential biomarkers that may help differentiate these types of diabetes. RECENT FINDINGS Recent studies have identified several complications (including nonvascular) that occur more frequently in patients with diabetes secondary to ac...
Source
#1Jaelim Cho (University of Auckland)H-Index: 15
#2Robert Scragg (University of Auckland)H-Index: 73
Last. Maxim S. Petrov (University of Auckland)H-Index: 28
view all 3 authors...
Abstract Background It is unknown whether cholecystectomy for acute pancreatitis (AP) affects the risk of post-pancreatitis diabetes mellitus (PPDM). We aimed to investigate the associations between cholecystectomy, recurrent biliary events prior to cholecystectomy, and the risk of PPDM in patients with AP. Methods Using New Zealand nationwide data from 2007 to 2016, patients with first admission for AP were identified (n = 10,870). Cholecystectomy was considered as a time-dependent exposure. Ti...
2 CitationsSource
#1Mark O. Goodarzi (NIH: National Institutes of Health)
#2Maxim S. PetrovH-Index: 28
Last. Phil A. HartH-Index: 29
view all 4 authors...
PURPOSE OF REVIEW The purpose of this review is to delineate risk factors for the development of diabetes in patients with chronic pancreatitis. The natural history including progression to diabetes and complications that develop once diabetes occurs in chronic pancreatitis is also reviewed. RECENT FINDINGS Studies have found that predictors of diabetes in chronic pancreatitis include both risk factors for type 2 diabetes (e.g., obesity, genetic variants) as well as pancreas-specific factors (e....
Source
Introduction The need for new drugs for diabetes is obvious. Albeit type 2 diabetes is the most common type of diabetes, it is fundamentally a disease of exclusion. Post-pancreatitis diabetes mellitus is one of the most common types of secondary diabetes. The pharmaceutical armamentarium in the field of diabetology can be broadened if the design of novel drugs is informed by pathogenetic insights from studies on post-pancreatitis diabetes mellitus. Areas covered The article provides an overview ...
1 CitationsSource
#1Joanna Wirkus (UC Davis: University of California, Davis)H-Index: 1
#2Aya S. Ead (UC Davis: University of California, Davis)
Last. Gerardo G. Mackenzie (UC Davis: University of California, Davis)H-Index: 27
view all 3 authors...
Abstract A significant number of pancreatic cancer cases are due to modifiable risk factors, with many being attributed to increased body fatness. This has sparked investigators to examine the role played by high dietary fat intake in pancreatic cancer development and the mechanisms driving this connection. However, there is currently no consensus on how dietary fat quantity and composition specifically affect pancreatic carcinogenesis. The objective of this narrative review is to discuss the li...
1 CitationsSource
#1Jaelim Cho (University of Auckland)H-Index: 15
#2Stephen J. Pandol (Cedars-Sinai Medical Center)H-Index: 74
Last. Maxim S. Petrov (University of Auckland)H-Index: 28
view all 3 authors...
Aims The aim was to investigate sex- and age-stratified risks of cause-specific death and life expectancy in individuals with post-pancreatitis diabetes mellitus (PPDM). Methods Nationwide data on mortality in New Zealand were obtained. For two head-to-head comparisons (PPDM versus type 2 diabetes mellitus [T2DM]; PPDM versus type 1 diabetes mellitus [T1DM]), the groups were matched on age, sex, and calendar year of diabetes diagnosis. Multivariable Cox regression analyses were conducted to esti...
5 CitationsSource
#1Stefano MeniniH-Index: 36
#2Carla IacobiniH-Index: 29
Last. Giuseppe PuglieseH-Index: 62
view all 5 authors...
Both type 2 (T2DM) and type 1 (T1DM) diabetes mellitus confer an increased risk of pancreatic cancer in humans. The magnitude and temporal trajectory of the risk conferred by the two forms of diabetes are similar, suggesting a common mechanism. Carbonyl stress is a hallmark of hyperglycemia and dyslipidemia, which accompanies T2DM, prediabetes, and obesity. Accumulating evidence demonstrates that diabetes promotes pancreatic ductal adenocarcinoma (PDAC) in experimental models of T2DM, a finding ...
7 CitationsSource
#1Jaelim Cho (University of Auckland)H-Index: 15
#2Robert Scragg (University of Auckland)H-Index: 73
Last. Maxim S. Petrov (University of Auckland)H-Index: 28
view all 4 authors...
It is well established that individuals with diabetes mellitus (DM) may develop exocrine pancreatic dysfunction (EPD) requiring pancreatic enzyme replacement therapy, whereas the converse relationship has been poorly studied. Pancreatitis is a disease that is well suited to investigate the latter as it is often characterized by the development of EPD and/or new-onset DM. The aim was to investigate the association between EPD and the risk of new-onset DM in individuals after the first attack of p...
8 CitationsSource